MYBL2 regulates de novo purine synthesis by transcriptionally activating IMPDH1 in hepatocellular carcinoma cells

BACKGROUND: Metabolic reprogramming is a hallmark of cancer, alteration of nucleotide metabolism of hepatocellular carcinoma (HCC) is not well-understood. MYBL2 regulates cell cycle progression and hepatocarcinogenesis, its role in metabolic regulation remains elusive. PATIENTS AND METHODS: Copy num...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jun-Zhang, Wang, Wei, Liu, Tao, Zhang, Lei, Lin, De-Zheng, Yao, Jia-Yin, Peng, Xiang, Jin, Gang, Ma, Tian-Tian, Gao, Jin-Bo, Huang, Fang, Nie, Jun, Lv, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733023/
https://www.ncbi.nlm.nih.gov/pubmed/36494680
http://dx.doi.org/10.1186/s12885-022-10354-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733023/
https://www.ncbi.nlm.nih.gov/pubmed/36494680
http://dx.doi.org/10.1186/s12885-022-10354-4

Ejemplares similares